Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic Acid and Riboflavin for CIN1 with High-Risk HPV
NCT00220532Phase 2Terminated
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jul 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of folic acid, riboflavin in cervical intraepithelial neoplasia (CIN), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Jul 2005; status: terminated.
02
Drugs
folic acidriboflavin
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT00220532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220532.